Y300-3091 Screening compound: N-(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-5-yl)(phenyl)methanesulfonamide

Y300-3091 Screening compound: N-(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-5-yl)(phenyl)methanesulfonamide
Y300-3091 Screening compound: N-(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-5-yl)(phenyl)methanesulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y300-3091
N-(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-5-yl)(phenyl)methanesulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y300-3091

Molecular Formula

C16H17N3O3S (C16 H17 N3 O3 S)

Compound Name

N-(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzimidazol-5-yl)(phenyl)methanesulfonamide

IUPAC name

n/a

SMILES

CN(c(ccc(NS(Cc1ccccc1)(=O)=O)c1)c1N1C)C1=O

InChI

InChI=1S/C16H17N3O3S/c1-18-14-9-8-13(10-15(14)19(2)16(18)20)17-23(21,22)11-12-6-4-3-5-7-12/h3-10,17H,11H2,1-2H3

InChI Key

HSMRBLJFHQIOGA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD09871451

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

331.4

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.279

Distribution Coefficient, logD

2.075

Water Solubility, LogSw

-2.92

Polar Surface Area

60.200

Acid Dissociation Constant (pKa)

7.62

Base Dissociation Constant (pKb)

-0.13

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.80

Y300-3091 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with Y300-3091 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y300-3091?
Check Price and Availability of Y300-3091, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y300-3091 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y300-3091
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y300-3091
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y300-3091 available by request